Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest)
Clinical trial NCT06690047 · COMPLETED
Trial details
- NCT number
- NCT06690047
- Sponsor
- Bernstein Clinical Research Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2022-04-28
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.